METUi001-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	METUi001-A
Cite as:	METUi001-A (RRID:CVCL_A8ML)
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	3rd May 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Middle East Technical University (METU)
External iPSC Databases
Cellosaurus	CVCL_A8ML
Wikidata	Q108820903
General iPSC Information
Publications	Begentas OC et al. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis. Stem cell research. 2021 May;53:102370. Begentas OC et al. Establishment of Human Induced Pluripotent Stem Cells from Multiple Sclerosis Patients. Methods in molecular biology (Clifton, N.J.). 2022;2549:43-67. Kiris E. Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases. Advances in experimental medicine and biology. 2022;1387:57-88. Ren Rutong et al. Research progress of autoimmune diseases based on induced pluripotent stem cells. Frontiers in Immunology. 2024-04-24. Simões-Abade Madalena B. C. et al. Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis. Frontiers in Cellular Neuroscience. 2024-12-18. Kavakli Ebru et al. Astrocytes in Primary Familial Brain Calcification (PFBC): Emphasis on the Importance of Induced Pluripotent Stem Cell-Derived Human Astrocyte Models. Advances in Experimental Medicine and Biology. 2025-00-00. Muñoz-San Martín María et al. From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis. International Journal of Molecular Sciences. 2025-09-08.

iPSC Derivation

General